With new clinical development offices in Chile and Peru, as well as expanded facilities in Argentina, US-based contract research organisation (CRO) Covance has broadened its presence in the emerging Latin American market.

The new offices in Santiago and Lima will support Covance staff in Chile and Peru respectively, including the network of field-based clinical research associates operating for the CRO throughout Latin America.

Covance has also expanded its office in Buenos Aires, Argentina, where it first established a foothold in the Latin American market in 1997. Before long, the CRO had an “extensive and highly trained” network of regional clinical trial monitors in place, it noted.

“Our strategy is to target areas for qualified patient populations and the most qualified investigators as we selectively expand our presence in key metropolitan centres in emerging regions such as Latin America,” explained Katie Margules, Covance’s senior director of project management in Latin America.

Covance said the new offices and expanded facilities in Latin America would help to speed up the execution of clinical studies with a full range of services, while building strategic relationships with investigators, trial sites and regulatory authorities “in a region known for its strong potential to contribute to high-quality global clinical trial conduct”.

According to Wayne Langlois, Covance’s vice president and general manager of clinical development services, Americas, the company is “committed to continuing to build our infrastructure across Latin America, expanding current facilities, and opening further new clinical offices to increase Phase III clinical trial productivity”.